James DeGregori

James DeGregori is an American cancer biologist, professor of biochemistry and molecular genetics at the University of Colorado Anschutz Medical Campus, known for formulating and testing the evolutionary theory of adaptive oncogenesis.
Adaptive oncogenesis and hematopoietic competition
Whereas classical mutation-centric models attribute rising cancer incidence with age primarily to cumulative mutation counts, DeGregori shifts the causal focus to tissue selective context.1 In young, intact tissues, wild-type stem and progenitor cells occupy a fitness peak, so oncogenic mutations rarely confer an advantage and often impose a fitness cost.2 When aging, chronic inflammation, or genotoxic injury impairs wild-type competitors, oncogenic alterations that restore survival or bypass damaged regulatory signals become positively selected.324
DeGregori and collaborators tested this prediction using competitive bone-marrow transplantation and chimeric progenitor assays in mice:
- Aged progenitors and Bcr-Abl selection. Old mouse B-lymphoid progenitors show reduced receptor-kinase and IL-7 signaling relative to young progenitors. Introducing Bcr-Abl gave clones little advantage in young marrow but rescued Akt and STAT5 signaling in aged progenitors, driving leukemic expansion.2
- Irradiation-induced niche selection. Ionizing radiation selects for p53-deficient hematopoietic progenitors primarily because it degrades the competitiveness of unmutated wild-type stem cells; restoring unirradiated wild-type competitors suppresses mutant expansion.3
- Chronic inflammation. Age-related systemic inflammation reduces normal B-progenitor vigor and accelerates selection for oncogenic clones, whereas suppressing inflammation preserves wild-type competitiveness and blunts leukemogenesis without altering mutation rates.4
DeGregori presented the full evolutionary synthesis in Adaptive Oncogenesis: A New Understanding of How Cancer Evolves Inside Us (2018).1
See also
References
Footnotes
- DeGregori J. Adaptive Oncogenesis: A New Understanding of How Cancer Evolves Inside Us. Harvard University Press, 2018. ↩↩2
- Henry CJ, Marusyk A, et al., DeGregori J. Declining lymphoid progenitor fitness promotes aging-associated leukemogenesis. Proceedings of the National Academy of Sciences. 2010;107(50):21713–21718. doi:10.1073/pnas.1005486107. ↩↩2↩3
- Marusyk A, DeGregori J, et al. Irradiation selects for p53-deficient hematopoietic progenitors. PLoS Biology. 2010. doi:10.1371/journal.pbio.1000324. ↩↩2
- Henry CJ, Casás-Selves M, Kim J, et al. Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors. Journal of Clinical Investigation. 2015. doi:10.1172/JCI83024. ↩↩2